W
Wynona Coles
Researcher at National Institutes of Health
Publications - 26
Citations - 3187
Wynona Coles is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Pulmonary hypertension & Sickle cell anemia. The author has an hindex of 14, co-authored 24 publications receiving 2932 citations.
Papers
More filters
Journal ArticleDOI
Pulmonary hypertension as a risk factor for death in patients with sickle cell disease
Mark T. Gladwin,Vandana Sachdev,Maria Jison,Yukitaka Shizukuda,Jonathan F. Plehn,Karin R. Minter,Bernice Brown,Wynona Coles,James S. Nichols,Inez Ernst,Lori A. Hunter,William C. Blackwelder,Alan N. Schechter,Griffin P. Rodgers,Oswaldo Castro,Frederick P. Ognibene +15 more
TL;DR: Pulmonary hypertension appears to be a complication of chronic hemolysis, is resistant to hydroxyurea therapy, and confers a high risk of death in adults with sickle cell disease.
Journal ArticleDOI
Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease.
Vandana Sachdev,Roberto F. Machado,Yukitaka Shizukuda,Yesoda N. Rao,Stanislav Sidenko,Inez Ernst,Marilyn St. Peter,Wynona Coles,Douglas R. Rosing,William C. Blackwelder,Oswaldo Castro,Gregory J. Kato,Mark T. Gladwin +12 more
TL;DR: Data from this study support the implementation of echocardiographic screening of adult patients with SCD to identify high-risk individuals for further evaluation and contribute independently to prospective mortality in patients withSCD.
Journal ArticleDOI
Divergent Nitric Oxide Bioavailability in Men and Women With Sickle Cell Disease
Mark T. Gladwin,Alan N. Schechter,Frederick P. Ognibene,Wynona Coles,Christopher D. Reiter,William H. Schenke,Gyorgy Csako,Myron A. Waclawiw,Julio A. Panza,Richard O. Cannon +9 more
TL;DR: NO bioavailability and NO responsiveness are greater in women than in men with sickle cell disease and determines adhesion molecule expression and endothelium-dependent blood flows are largely non-NO mediated in male patients.
Journal ArticleDOI
Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype
Matthew M. Hsieh,Courtney D. Fitzhugh,R. Patrick Weitzel,Mary E. Link,Wynona Coles,Xiongce Zhao,Griffin P. Rodgers,Jonathan D. Powell,John F. Tisdale +8 more
TL;DR: Among 30 patients with sickle cell phenotype with or without thalassemia who underwent nonmyeloablative allogeneic HSCT, the rate of stable mixed-donor chimerism was high and allowed for complete replacement with circulating donor red blood cells among engrafted participants.
Journal ArticleDOI
Hemodynamic and Functional Assessment of Patients with Sickle Cell Disease and Pulmonary Hypertension
Anastasia Anthi,Roberto F. Machado,Maria Jison,Angelo M. Taveira-DaSilva,Lewis J. Rubin,Lori A. Hunter,Christian J. Hunter,Wynona Coles,James S. Nichols,Nilo A. Avila,Vandana Sachdev,Clara C. Chen,Mark T. Gladwin +12 more
TL;DR: Patients with SCD-associated PH have both pulmonary arterial and venous PH associated with severe limitations in exercise capacity, likely compounded by interstitial lung fibrosis and severe anemia, and the use of the six-minute-walk distance as an index of PH and cardiopulmonary function is supported.